<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00974415</url>
  </required_header>
  <id_info>
    <org_study_id>STU11387</org_study_id>
    <nct_id>NCT00974415</nct_id>
  </id_info>
  <brief_title>Study of the Carbon Dioxide Treatment for Fat Reduction</brief_title>
  <official_title>A Pilot Study of the Carbon Dioxide Treatment for Fat Reduction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to demonstrate the efficacy and safety of the carbon&#xD;
      dioxide for subcutaneous fat reduction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of flank circumference</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>10-point pain visual analog scale</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any adverse events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction, determined by using patient satisfaction questionnaires.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CO2 treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2</intervention_name>
    <description>CO2 treatment delivered to randomized flank at each study visit</description>
    <arm_group_label>treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>Sham treatment to other flank at each study visit</description>
    <arm_group_label>sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Male or female subject ages â‰¥ 18 years old&#xD;
&#xD;
          -  Body mass index (BMI) between 18.5-24.99. (BMI is defined as weight in pounds&#xD;
             multiplied by 703 divided by the square of the height in inches).&#xD;
&#xD;
        Subject in good health&#xD;
&#xD;
          -  Willing and able to abstain from partaking in any treatment other than the study&#xD;
             procedure (existing or new) to promote body contouring and/or weight loss during the&#xD;
             course of study participation.&#xD;
&#xD;
          -  Subject agrees to maintain their weight (i.e. within 5 pounds) by not making any&#xD;
             changes to diet or lifestyle during the study.&#xD;
&#xD;
          -  The subject has the willingness and the ability to understand and provide informed&#xD;
             consent for the use of their tissue and communicate with the investigator&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Pregnant or lactating or intends to become pregnant in the next 9 months.&#xD;
&#xD;
          -  Unable to understand the protocol or to give informed consent&#xD;
&#xD;
          -  Any previous and/or pending procedures at the treatment area or that may likely affect&#xD;
             the treatment area&#xD;
&#xD;
          -  Pending and/or anticipated major change in diet or exercise pattern in the six weeks&#xD;
             following the last treatment or who has taken diet pills within the last 6 months.&#xD;
&#xD;
          -  History of asthma or chronic obstructive pulmonary diseases&#xD;
&#xD;
          -  Active skin disease or skin infection in the treatment area&#xD;
&#xD;
          -  Bleeding tendency or coagulopathy&#xD;
&#xD;
          -  Subject who are allergic to lidocaine&#xD;
&#xD;
          -  Any other condition that would, in the professional opinion of the investigator,&#xD;
             potentially affect response or participation in the clinical study, or would pose as&#xD;
             an unacceptable risk to the subject&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murad Alam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dennis P West, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 9, 2009</study_first_submitted>
  <study_first_submitted_qc>September 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2009</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Murad Alam</investigator_full_name>
    <investigator_title>Professor of Dermatology</investigator_title>
  </responsible_party>
  <keyword>BMI classification-overweight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

